Lupin to train over 1,000 graduates for pharma industry
Mumbai-based Lupin expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its ‘Learn and Earn Initiative’.
Under this initiative, candidates who have passed Standard 12 in the science stream with a minimum of 50 per cent marks but are facing financial constraints, are taken for three-year-long course during which they are paid stipend and provided all facilities.
According to Mr. Yashwant Mahadik, President, Global Human Resource, Lupin, the programme was conceptualised in 2010 due an acute shortage of skilled manpower. “Historically, Lupin was recruiting 1,000 plus fresh graduates every year with no relevant job skill, and sensed that there was a need of job-ready graduates with appropriate technical and life skills,” he said.
Mr. C. Srinivasalu, Senior Vice President (HR), Lupin, informed that since 2011 the company has helped create a total of 560 graduates with 181 students passing out in 2018. “We expect to graduate more than 1,000 students by 2020 adding to the manpower resource of the pharmaceutical sector,” he said.
The company has initiated the ‘Learn and Earn Initiative’ at its facilities in Goa, Tarapur (Maharashtra), Indore (MP), Aurangabad (Maharashtra) and Sikkim, he added.
During the course period, the candidate undergoes five days on-the-job training with one day of classroom session. Further, the students have to compulsorily work with Lupin for two years, after completing their course before they have their options open to join any other pharmaceutical firm.
Lupin has estimated that by the year 2020 it would be spending almost Rs. 20-crore on this programme. This programme will bridge the manpower requirement of pharmaceutical sector in a big way, said Mr. Srinivasalu.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
South Korea Approves Yeosu Restructuring Plan, Permanently Retiring 1.39 Million Tons of Ethylene Capacity
-
European Petrochemicals Enter 'Era of Downsizing' as Dow, TotalEnergies, Shell Exit Older Cracker Assets
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
Global Oil Inventories Fall: Restocking Demand May Keep Petrochemical Costs Supported
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
Recommend Reading
-
DKSH Opens Newly Enhanced Innovation Center in South Korea
-
New Titanium Dioxide Alternative Moves Closer to Market
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
This week, the price of petroleum coke from independent refineries in China has slightly increased
-
MTBE Market Shows Slight Fluctuations
-
Narrow Fluctuations in Methanol Market Conditions
-
This Week, Local Refinery Gasoline and Diesel Prices Remain Sluggish in China (8.31-9.5)
-
September Isopropanol Market Prices First Rise Then Fall